Undertreatment of Hepatitis C Virus Infection in Elective Total Hip Arthroplasty
Total Hip Arthroplasty (THA) in patients with hepatitis C virus (HCV) are known for poor outcomes increased risk of iatrogenic infection. New Direct Antiviral Agents (DAA) can now cure HCV infection. However, undertreatment is still common in patients undergoing THA. Our aim was to assess the prevalence of HCV infection and treatment rates inpatients with …
Undertreatment of Hepatitis C Virus Infection in Elective Total Hip Arthroplasty Read More »